XML 150 R135.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule II. Condensed Financial Information Of Registrant (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows (used in) provided by operating activities      
Net income (loss) attributable to RenaissanceRe $ (40,155) $ 762,405 $ 748,798
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities      
Net realized and unrealized (gains) losses on investments 205,897 (820,636) (414,109)
Other (437,221) 178,314 238,756
Net cash provided by (used in) operating activities 1,234,815 1,992,735 2,137,195
Cash flows used in investing activities      
Proceeds from maturities and sales of fixed maturity investments trading 15,543,565 15,186,952 17,313,940
Purchases of fixed maturity investments trading (15,680,351) (16,836,538) (17,919,343)
Net purchases of short term investments (252,833) (581,473) (1,900,741)
Net cash provided by (used in) investing activities (816,296) (2,304,689) (2,988,644)
Cash flows provided by (used in) financing activities      
Dividends paid – RenaissanceRe common shares (67,828) (68,490) (59,368)
Dividends paid – preference shares (32,889) (30,923) (36,756)
Issuance of debt, net of expenses 0 0 396,411
RenaissanceRe common share repurchases (1,027,505) (62,621) 0
RenaissanceRe common share issuance 0 1,095,507 0
Redemption of preference shares (275,000) (125,000) 0
Issuance of preference shares, net of expenses 488,653 0 0
Taxes paid on withholding shares (12,171) (12,330) (7,253)
Net cash provided by (used in) financing activities (302,461) 665,214 1,120,117
Effect of exchange rate changes on foreign currency cash 6,148 4,485 2,478
Net increase (decrease) in cash and cash equivalents 122,206 357,745 271,146
Cash and cash equivalents, beginning of year 1,736,813 1,379,068 1,107,922
Cash and cash equivalents, end of year 1,859,019 1,736,813 1,379,068
Parent Company      
Cash flows (used in) provided by operating activities      
Net income (loss) attributable to RenaissanceRe (40,155) 762,405 748,798
Less: equity in net income of subsidiaries 10,670 (786,552) (773,419)
Loss before equity in net income of subsidiaries (29,485) (24,147) (24,621)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities      
Net realized and unrealized (gains) losses on investments 4,898 4,556 (12,393)
Other 59,873 37,782 34,153
Net cash provided by (used in) operating activities 35,286 18,191 (2,861)
Cash flows used in investing activities      
Proceeds from maturities and sales of fixed maturity investments trading 436,122 370,905 306,579
Purchases of fixed maturity investments trading (421,323) (384,415) (66,740)
Net purchases of short term investments 78,904 64,209 (116,499)
Dividends and return of capital from subsidiaries 1,104,831 827,626 1,400,944
Contributions to subsidiaries (351,548) (1,623,708) (1,165,607)
Due (to) from subsidiary 50,472 (65,438) (625,924)
Net cash provided by (used in) investing activities 897,458 (810,821) (267,247)
Cash flows provided by (used in) financing activities      
Dividends paid – RenaissanceRe common shares (67,828) (68,490) (59,368)
Dividends paid – preference shares (32,889) (30,923) (36,756)
Issuance of debt, net of expenses 0 0 396,411
RenaissanceRe common share repurchases (1,027,505) (62,621) 0
RenaissanceRe common share issuance 0 1,095,507 0
Redemption of preference shares (275,000) (125,000) 0
Issuance of preference shares, net of expenses 488,653 0 0
Taxes paid on withholding shares (12,171) (12,330) (7,253)
Net cash provided by (used in) financing activities (926,740) 796,143 293,034
Effect of exchange rate changes on foreign currency cash 0 (143) 0
Net increase (decrease) in cash and cash equivalents 6,004 3,370 22,926
Cash and cash equivalents, beginning of year 29,830 26,460 3,534
Cash and cash equivalents, end of year $ 35,834 $ 29,830 $ 26,460